Jolijn Brouwer

905 total citations
14 papers, 639 citations indexed

About

Jolijn Brouwer is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jolijn Brouwer has authored 14 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Otorhinolaryngology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Jolijn Brouwer's work include Head and Neck Cancer Studies (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jolijn Brouwer is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jolijn Brouwer collaborates with scholars based in Netherlands and United Kingdom. Jolijn Brouwer's co-authors include C. René Leemans, Otto S. Hoekstra, Jonas A. Castelijns, Nic J.G.M. Veeger, Remco de Bree, Remco de Bree, Min Ki ten Kate, Willem M. Lijfering, Emile F.I. Comans and Hanneke C. Kluin‐Nelemans and has published in prestigious journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis and The Laryngoscope.

In The Last Decade

Jolijn Brouwer

14 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolijn Brouwer Netherlands 12 354 198 180 156 146 14 639
W. Halfpenny United Kingdom 9 148 0.4× 206 1.0× 74 0.4× 32 0.2× 144 1.0× 18 440
Joy K Rahman United Kingdom 6 367 1.0× 240 1.2× 108 0.6× 48 0.3× 150 1.0× 11 572
Robert Clough United States 9 268 0.8× 202 1.0× 162 0.9× 22 0.1× 330 2.3× 11 599
Alastair N.J. Graham United Kingdom 15 23 0.1× 330 1.7× 192 1.1× 90 0.6× 437 3.0× 44 828
Matthew Beasley United Kingdom 14 386 1.1× 345 1.7× 151 0.8× 5 0.0× 275 1.9× 45 703
S.H. Levitt United States 12 85 0.2× 239 1.2× 108 0.6× 10 0.1× 134 0.9× 27 462
Minoru Kamata Japan 17 179 0.5× 324 1.6× 294 1.6× 27 0.2× 312 2.1× 48 785
Remy Lim United States 10 87 0.2× 73 0.4× 54 0.3× 10 0.1× 166 1.1× 16 427
A. Turlakow Australia 8 40 0.1× 159 0.8× 54 0.3× 10 0.1× 134 0.9× 9 363
Xun Yang China 14 22 0.1× 274 1.4× 377 2.1× 15 0.1× 178 1.2× 47 574

Countries citing papers authored by Jolijn Brouwer

Since Specialization
Citations

This map shows the geographic impact of Jolijn Brouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolijn Brouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolijn Brouwer more than expected).

Fields of papers citing papers by Jolijn Brouwer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolijn Brouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolijn Brouwer. The network helps show where Jolijn Brouwer may publish in the future.

Co-authorship network of co-authors of Jolijn Brouwer

This figure shows the co-authorship network connecting the top 25 collaborators of Jolijn Brouwer. A scholar is included among the top collaborators of Jolijn Brouwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolijn Brouwer. Jolijn Brouwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Korteweg, Fleurisca J., Nienke Folkeringa, Jolijn Brouwer, et al.. (2013). Fetal Loss in Women With Hereditary Thrombophilic Defects and Concomitance of Other Thrombophilic Defects. Obstetric Anesthesia Digest. 33(2). 112–113. 1 indexed citations
2.
Mahmoodi, Bakhtawar K., Jolijn Brouwer, Min Ki ten Kate, et al.. (2010). A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. Journal of Thrombosis and Haemostasis. 8(6). 1193–1200. 85 indexed citations
3.
Brouwer, Jolijn, Remco de Bree, Emile F.I. Comans, et al.. (2008). Improved detection of recurrent laryngeal tumor after radiotherapy using 18FDG-PET as initial method. Radiotherapy and Oncology. 87(2). 217–220. 17 indexed citations
4.
Brouwer, Jolijn, et al.. (2008). The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. European Archives of Oto-Rhino-Laryngology. 266(9). 1441–1448. 14 indexed citations
5.
Brouwer, Jolijn, Lotty Hooft, Otto S. Hoekstra, et al.. (2008). Systematic review: Accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head & Neck. 30(7). 889–897. 35 indexed citations
6.
Brouwer, Jolijn, Willem M. Lijfering, Min Ki ten Kate, et al.. (2008). High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thrombosis and Haemostasis. 101(1). 93–99. 94 indexed citations
7.
Bree, Remco de, Lisa van der Putten, Jolijn Brouwer, et al.. (2008). Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncology. 45(4-5). 386–393. 68 indexed citations
8.
Veeger, Nic J.G.M., et al.. (2007). The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels. Haematologica. 92(12). 1703–1706. 19 indexed citations
9.
Brouwer, Jolijn, Remco de Bree, Otto S. Hoekstra, et al.. (2005). Screening for Distant Metastases in Patients With Head and Neck Cancer: Is Chest Computed Tomography Sufficient?. The Laryngoscope. 115(10). 1813–1817. 57 indexed citations
10.
Brouwer, Jolijn, Asaf Senft, Remco de Bree, et al.. (2005). Screening for distant metastases in patients with head and neck cancer: Is there a role for 18FDG-PET?. Oral Oncology. 42(3). 275–280. 58 indexed citations
11.
Brouwer, Jolijn, et al.. (2003). Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement. European Archives of Oto-Rhino-Laryngology. 261(8). 417–22. 39 indexed citations
12.
Brouwer, Jolijn, Remco de Bree, Emile F.I. Comans, et al.. (2003). Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?. European Archives of Oto-Rhino-Laryngology. 261(9). 479–483. 42 indexed citations
13.
Tiwari, Rammohan, et al.. (2002). Squamous cell carcinoma of the external auditory canal and middle ear results of treatment with subtotal temporal bone resection and postoperative radiotherapy. Indian Journal of Otolaryngology and Head & Neck Surgery. 54(3). 179–183. 2 indexed citations
14.
Brouwer, Jolijn, Remco de Bree, Jan Pruim, et al.. (2002). Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. European Journal of Nuclear Medicine and Molecular Imaging. 29(8). 1024–1030. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026